Cho A, Glinka T W, Ludwikow M, Fan A T, Wang M, Hecker S J
Microcide Pharmaceuticals, Inc., Mountain View, CA 94043, USA.
Bioorg Med Chem Lett. 2001 Jan 22;11(2):137-40. doi: 10.1016/s0960-894x(00)00603-x.
Incorporation of a basic aminopyridine into the C-7 position of 3-(amine-substituted arylthio)-3-norcephalosporins, as in 3, afforded high potency against MRSA and acceptable solubility for intravenous administration.
将一种碱性氨基吡啶引入3-(胺基取代芳硫基)-3-去甲头孢菌素的C-7位,如化合物3所示,对耐甲氧西林金黄色葡萄球菌(MRSA)具有高效活性,且具有适合静脉给药的溶解度。